Dover (DOV) AI Stock Analysis

• Market Cap: $24.66B
• Dividend Yield: 1.14%
• Average Volume (3M): 1.32M
• Price to Earnings (P/E): 10.8
• Beta (1Y): 1.17
• Revenue Growth: -5.86%
• EPS Growth: 59.79%
• Country: US
• Employees: 24,000
• Sector: Industrials
• Sector Strength: 92
• Industry: Industrial - Machinery
• EPS (TTM): 2.05
• Shares Outstanding: 137,104,370
• 10 Day Avg. Volume: 953,685
• 30 Day Avg. Volume: 1,318,025
• PEG Ratio: -0.71
• Price to Book (P/B): 3.33
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 41.83
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $202.91
• Price Target Upside: 14.06% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 12

• Rating: 80 Outperform
• Price Target: $207.00 ▲( 16.36% Upside)

Dover's overall stock score is driven by strong financial performance and positive earnings call insights, supported by attractive valuation metrics. Technical analysis indicates potential for moderate price appreciation, while the company's strategic focus and resilience are tempered by tariff concerns and specific segment challenges.

Positive Factors

Financial Performance

The portfolio transformation focusing on acquisitions is expected to accelerate EPS and EBITDA growth, acting as a catalyst for stock re-rating.

Growth Opportunities

Dover Corporation's increased exposure to secular growth markets like Biopharma and Clean Energy positions it for better growth.

Operational Efficiency

Dover Corporation has expanded margins impressively, indicating strong operational resilience despite volume and mix headwinds.

Negative Factors

Growth Sustainability

There is concern about the durability of Dover Corporation's growth, as it might fade back to lower levels if comparisons normalize.

Market Challenges

SWEP and Belvac's continued weakness is dragging down DCST organic growth, though sequential bookings momentum could provide a boost.

Dover Business Overview & Revenue Model

Company Description

Dover Corporation (DOV) is a diversified global manufacturer that delivers innovative equipment and components, specialty systems, and support services through a broad range of industries, including energy, engineered systems, fluids, and refrigeration & food equipment. The company operates through several segments, providing highly engineered products and solutions to its customers worldwide, ensuring operational efficiency and enhanced productivity.

How the Company Makes Money

Dover Corporation makes money through the manufacturing and sale of its wide range of products and services across its various business segments. Its revenue streams are primarily derived from the sale of industrial products, including pumps, compressors, refrigeration systems, and printing and identification equipment. Additionally, the company earns through the provision of aftermarket services, including maintenance and support. Significant partnerships and long-term contracts with industries in energy, food and beverage, and transportation further bolster their revenue. Additionally, Dover leverages its innovative capabilities and global reach to maintain a competitive edge in the industrial manufacturing sector.

Dover Financial Statement Overview

Summary

Dover exhibits strong financial health, with robust profitability metrics, a solid balance sheet, and good cash flow generation. The company maintains high margins and a strong equity base, though revenue growth is modest.

Income Statement

Dover's income statement shows robust financial health with a strong net profit margin of 28.84% in the TTM. The gross profit margin for the TTM is 38.65%, indicating efficient production processes. Despite a slight decline in revenue from 2023 to TTM, the company demonstrates strong profitability metrics, with EBIT and EBITDA margins of 16.27% and 20.82%, respectively. The revenue growth rate from 2024 to TTM is a modest 2.73%, suggesting stable revenue generation but room for improvement in growth.

Balance Sheet

Dover maintains a solid balance sheet with a debt-to-equity ratio of 0.42 for TTM, reflecting prudent financial leverage. The equity ratio of 56.44% indicates a strong equity base relative to total assets. Return on equity is a remarkable 32.16%, showcasing effective use of shareholder equity to generate profits. Overall, the company shows a strong balance sheet with manageable debt levels, although there is potential risk if debt levels rise significantly.

Cash Flow

The cash flow statement reveals strong operational efficiency with an operating cash flow to net income ratio of 0.32 in TTM, indicating that the company generates sufficient cash from operations relative to its net income. The free cash flow to net income ratio is 0.25, which, although slightly lower, still reflects positive cash flow health. Additionally, the free cash flow growth rate from 2024 to TTM is 2.21%, suggesting steady cash generation capabilities.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
7.96B	7.75B	8.44B	8.51B	7.91B	6.68B
	Gross Profit
3.08B	2.96B	3.08B	3.06B	2.97B	2.47B
	EBIT
1.29B	1.21B	1.37B	1.38B	1.28B	932.99M
	EBITDA
1.77B	2.23B	1.72B	1.71B	1.80B	1.23B
	Net Income Common Stockholders
2.30B	2.70B	1.06B	1.07B	1.12B	683.45M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.81B	1.84B	398.56M	380.87M	385.50M	513.08M
	Total Assets
12.65B	12.51B	11.35B	10.90B	10.40B	9.15B
	Total Debt
2.97B	2.93B	3.68B	3.68B	3.12B	3.11B
	Net Debt
1.17B	1.08B	3.28B	3.30B	2.74B	2.60B
	Total Liabilities
5.51B	5.56B	6.24B	6.61B	6.21B	5.77B
	Stockholders Equity
7.14B	6.95B	5.11B	4.29B	4.19B	3.39B
Cash Flow		Free Cash Flow
567.15M	580.85M	1.14B	584.76M	944.40M	939.12M
	Operating Cash Flow
738.40M	748.38M	1.34B	805.72M	1.12B	1.10B
	Investing Cash Flow
1.45B	1.96B	-726.63M	-540.92M	-992.75M	-481.38M
	Financing Cash Flow
-1.31B	-1.27B	-568.06M	-260.26M	-249.88M	-506.29M

Dover Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 177.89
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DOV, the sentiment is Negative. The current price of 177.89 is above the 20-day moving average (MA) of 177.66, above the 50-day MA of 173.26, and below the 200-day MA of 186.90, indicating a neutral trend. The MACD of 2.89 indicates Positive momentum. The RSI at 51.29 is Neutral, neither overbought nor oversold. The STOCH value of 22.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DOV.

Dover Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DOV	80 Outperform	$24.66B	10.83	17.45%	1.14%	-5.86%	59.79%
IEX	75 Outperform	$13.68B	28.69	12.73%	1.52%	1.66%	-17.18%
IR	74 Outperform	$33.46B	40.99	8.09%	0.10%	5.27%	0.61%
XYL	72 Outperform	$30.48B	33.70	8.62%	1.18%	8.14%	32.64%
NDSN	71 Outperform	$11.15B	24.94	16.15%	1.54%	0.78%	-8.42%
ROK	68 Neutral	$34.44B	38.47	25.86%	1.67%	-11.19%	-22.50%
Sector *	64 Neutral	$4.39B	11.81	5.20%	249.38%	3.96%	-12.36%

Dover Corporate Events

Dover Holds Annual Shareholders Meeting, Elects Directors

On May 2, 2025, Dover Corporation held its Annual Meeting of Shareholders, where nine directors were elected, PricewaterhouseCoopers LLP was ratified as the independent auditor for 2025, and the compensation of named executive officers was approved. However, a proposal for an independent board chair was rejected, reflecting the company’s current governance structure and shareholder sentiment.

Dover Reports Q1 2025 Financial Results

On April 24, 2025, Dover announced its financial results for the first quarter ended March 31, 2025, reporting a 1% decrease in revenue to $1.9 billion compared to the previous year. Despite a 60% drop in GAAP earnings from continuing operations due to a prior year’s gain on disposition, adjusted earnings rose by 18%, and adjusted diluted EPS increased by 19%. The company highlighted strong demand and order trends across its segments, particularly in biopharma components and CO2 systems, and maintained a positive outlook for the near term, supported by a robust backlog and exceptional margin performance.